Lab data

Ipamorelin test results: how often vials pass lab testing

Ipamorelin had one of the better pass rates of the 14 peptides we track. CJC-1295, the compound it is usually paired with, had one of the worst.

12 November 2026 3 min read By Peptide AI Editorial policy

Of the last 197 Ipamorelin samples with a result in Finnrick's public lab-testing database, 139 passed and 58 failed: 71 percent of Ipamorelin test results were a pass. Another 3 came back incomplete and are left out. Finnrick has published 465 Ipamorelin tests from 94 sellers since 13 Feb 2025.

Ipamorelin is a selective ghrelin-receptor agonist first described in the late 1990s, studied for raising growth hormone with less effect on cortisol and prolactin than older compounds. It is a research compound, not an approved therapy, and it is most often discussed as half of a stack with CJC-1295.

The short version

  • 71 percent of recent samples passed. 139 passed and 58 failed, of the last 197 with a result.
  • It is not FDA-approved. FDA's compounding committee voted against it in 2024, and it is not in HHS's 2026 draft policy.
  • A pass is a narrow result. It covers identity, purity and fill for the vial that was tested. It does not cover endotoxin, sterility or the next batch.
  • We do not name sellers. The numbers describe the market, not any one shop.

Ipamorelin test results in numbers

MeasureIpamorelin
Published tests465
Sellers with at least one test94
First and latest test13 Feb 2025 to 5 Nov 2026
Recent results counted197 (3 incomplete left out)
Passed139
Failed58
Pass rate71%
Rank by pass rate2 of 14 on our peptide test results page

Figures from Finnrick's public Ipamorelin page, checked on 12 November 2026. They will change as new results come in.

What counts as a pass or a fail

These figures use Finnrick's "Purity focus" standard, the one its public pages show. A sample passes when its purity is at least 99.5 percent and the amount in the vial is within 35 percent of the label. A sample that turns out to be a different molecule fails under every standard Finnrick uses. Endotoxin testing is not required under this standard, so a pass says nothing about endotoxin or sterility.

The pass rate counts passes and fails among the most recent results on Finnrick's public page, up to 200, and leaves out tests that came back incomplete. Finnrick says it sources samples from sellers and sends them to third-party labs, with HPLC as the main method. Its methodology page has the detail.

Is ipamorelin FDA-approved?

No (see our ipamorelin page). FDA's Pharmacy Compounding Advisory Committee voted against ipamorelin acetate on 29 October 2024, 0 to 12 with one abstention, and FDA cited reports of "serious adverse events including death when ipamorelin was administered intravenously". It remains in Category 2 for 503B outsourcing facilities. Our page on FDA Category 2 peptides has the detail. It is not among the six peptides in HHS's October 2026 draft compounding policy.

A better pass rate than the peptide it is paired with

Of the last 197 ipamorelin samples with a result, 139 passed and 58 failed, second best of the 14 on our peptide test results page. CJC-1295, its usual partner, passed 39 percent. Someone who buys the pair is buying one of the better-testing compounds and one of the worst.

Finnrick has published 465 ipamorelin tests from 94 sellers since 13 Feb 2025. A better pass rate does not change the regulatory picture above.

Before you buy Ipamorelin

There is no approved ipamorelin product and no pharmacy route for it. A prescription is not an option today.

Before any order, three checks come first: the steps in how to vet a peptide supplier, an independent result for your own lot (how to get peptides tested), and the legal picture in is it legal to buy peptides. Products sold as research use only are not FDA-approved drugs, and a passing test does not make one safe to use.

Peptide AI is building a marketplace with two ways to buy: on a prescription through licensed telehealth, for what can legally be prescribed, or from vetted suppliers with an independent lab report you read before you order. It is not open yet. Early access is here.

Questions people ask

What percentage of Ipamorelin fails lab testing?

In Finnrick's public test database, 58 of the last 197 Ipamorelin samples with a result failed, which is 29 percent, and 139 passed. Tests that came back incomplete are left out.

Is Ipamorelin FDA-approved?

It is not FDA-approved. FDA's compounding committee voted against it in 2024, and it is not in HHS's 2026 draft policy.

Does a passing lab test mean Ipamorelin is safe?

No. A pass means the sample matched its label on identity, purity and fill under one standard. It does not cover endotoxin, sterility, other vials, or whether Ipamorelin is safe or does anything in people.

Do ipamorelin and CJC-1295 test the same?

No. In the same database, ipamorelin passed 71 percent of recent samples and CJC-1295 passed 39 percent. Each vial needs its own result.

Sources

  1. Methodology, Finnrick, accessed 12 November 2026
  2. Ipamorelin product page and public test history, Finnrick, accessed 12 November 2026
Free on iOS and Android

Log it once. See it all on one timeline.

Doses, food, training, labs, sleep and scans on one timeline. On iOS and Android.

The PeptideAI protocol screen with a weekly GLP-1 dose on it.